Skip to main content
. 2023 Jun 24;9(7):FSO878. doi: 10.2144/fsoa-2023-0049

Figure 1. . Progression-free survival (left) and overall survival (right) in patients with neutrophil-to-lymphocite ratio >3 or <3.

Figure 1. 

HR: Hazard ratio; NLR: Neutrophil-to-lymphocite ratio; OS: Overall survival; PFS: Progression-free survival.